Featured Articles
 
 
Preliminary Report of Remdesivir Trial Shows Improved Recovery Time in Severe COVID-19
Although several therapeutic agents have been evaluated for the treatment of COVID-19, none have yet shown to be effective.
Read more
 
 
FDA Grants Priority Review to Mepolizumab for Hypereosinophilic Syndrome
Officials with the FDA have granted priority review for mepolizumab (Nucala, GlaxoSmithKline) in the treatment of patients with hypereosinophilic syndrome.
Read more
Read More
 
Making the Shingrix Call
Galcanezumab Improves Work Productivity, Health and Well-Being in Patients With Migraine
Filgotinib Trial Shows Positive Results in Ulcerative Colitis
FDA Approves Dupilumab for Atopic Dermatitis in Children